Clinical Trial Update: Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neutron radiation therapy with pembrolizumab in advanced urothelial carcinoma; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Neutron Radiation Therapy
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Washington | Conditions: Urothelial Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-11-20